Joseph Massaro, PhD

Professor, Biostatistics
Joseph Massaro
(617) 638-7728jmm@bu.edu
Crosstown Center – CT327
View full profile at BUMC

Biography

Joe Massaro is Assistant Professor of Biostatistics, Mathematics and Statistics. He currently teaches Applied Statistical Methods in Clinical Trials I and II in the Department of Biostatistics. He has won several teaching awards at the School of Public Health for these courses. Joe currently also serves as Managing Director of Biostatistics and Data Management at Harvard Clinical Research Institute, a contract research organization providing statistical and data management services for the device, pharmaceutical and biotechnology industries. Overall, he has over 15 years experience in the design and statistical analysis of clinical trials, and has co-authored several clinical trials-related articles. Joe also performs longitudinal statistical analysis for the Framingham Heart Study, assessing risk factors for cardiovascular disease and dementia. In addition, he assists in the oversight of data management at the Framingham Heart Study. He has been with the Department of Biostatistics and the Framingham Heart Study since 1998.

Other Positions:

  • Biostatistician, Framingham Heart Study
  • Boston Medical Center

Education

  • Boston College, BA
  • Boston University, MA
  • Boston University, PhD

Classes Taught

  • SPHBS851
  • SPHBS851

Publications

  • Published on 3/17/2015

    Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, Massaro JM, Lewis BA, Cerezo J, Oldenburg NC, Thum CC, Jaff MR, Comerota AJ, Steffes MW, Abrahamsen IH, Goldberg S, Hirsch AT. Supervised Exercise, Stent Revascularization, or Medical Therapy for Claudication Due to Aortoiliac Peripheral Artery Disease: The CLEVER Study. J Am Coll Cardiol. 2015 Mar 17; 65(10):999-1009.

    Read at: PubMed
  • Published on 3/17/2015

    Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L. Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. JAMA. 2015 Mar 17; 313(11):1113-21.

    Read at: PubMed
  • Published on 3/3/2015

    Murabito JM, Pedley A, Massaro JM, Vasan RS, Esliger D, Blease SJ, Hoffman U, Fox CS. Moderate-to-Vigorous Physical Activity With Accelerometry is Associated With Visceral Adipose Tissue in Adults. J Am Heart Assoc. 2015; 4(3).

    Read at: PubMed
  • Published on 3/1/2015

    Kiernan MS, Gregory D, Sarnak MJ, Rossignol P, Massaro J, Kociol R, Zannad F, Konstam MA. Early and late effects of high- versus low-dose Angiotensin receptor blockade on renal function and outcomes in patients with chronic heart failure. JACC Heart Fail. 2015 Mar; 3(3):214-23.

    Read at: PubMed
  • Published on 1/1/2015

    Rosenquist KJ, Massaro JM, Pedley A, Long MT, Kreger BE, Vasan RS, Murabito JM, Hoffmann U, Fox CS. Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. J Clin Endocrinol Metab. 2015 Jan; 100(1):227-34.

    Read at: PubMed
  • Published on 12/18/2014

    Rosenquist KJ, Therkelsen KE, Massaro JM, Hoffmann U, Fox CS. Development and reproducibility of a computed tomography-based measurement for upper body subcutaneous neck fat. J Am Heart Assoc. 2014; 3(6).

    Read at: PubMed
  • Published on 11/18/2014

    Fox CS, Bonaca MA, Ryan JJ, Massaro JM, Barry K, Loscalzo J. A randomized trial of social media from circulation. Circulation. 2015 Jan 6; 131(1):28-33.

    Read at: PubMed
  • Published on 11/16/2014

    Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O''Neill WW, Patel MR, Rocha-Singh K, Sobotka PA, Svetkey L, Townsend RR, Bakris GL. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J. 2015 Jan 21; 36(4):219-27.

    Read at: PubMed
  • Published on 11/16/2014

    Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014 Dec 4; 371(23):2155-66.

    Read at: PubMed
  • Published on 9/16/2014

    Andersson C, Lyass A, Vasan RS, Massaro JM, D''Agostino RB, Robins SJ. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study. Am Heart J. 2014 Dec; 168(6):878-883.e1.

    Read at: PubMed

View 196 more publications:View full profile at BUMC